Enhancing drug development with human muscle platforms
In this interview, News-Medical LifeSciences speaks with Professor Mark Lewis, Co-Founder and CEO of Myomaker Bio, about the development…
Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity
Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune…